Relevance to NICE guidance programmes
The use of colesevelam for bile acid malabsorption is not appropriate for referral for a NICE technology appraisal and it is not currently planned into any other work programme.
NICE has issued diagnostic guidance on SeHCAT (tauroselcholic [75selenium] acid) for the investigation of diarrhoea due to bile acid malabsorption in people with diarrhoea-predominant irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection (NICE diagnostics guidance 7). This recommends SeHCAT for use in research for diagnosing bile malabsorption in these groups.